Boston Scientific Agrees To Pay $4.2Bn For UK Interventional Oncology Firm BTG
Executive Summary
A busy year of M&A for Boston Scientific just got busier with a $4.2bn cash offer for UK interventional medicine specialist BTG. Completion is expected by mid-year 2019.